These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9182443)

  • 1. [Limitations of ultrasonography in the clinical course monitoring of bladder tumors].
    Paez Borda A; Lujan Galán M; Martín Oses E; Gago Juan A; Fernández González I; Llorente Abarca C; Berenguer Sánchez A
    Actas Urol Esp; 1997 Jan; 21(1):34-9. PubMed ID: 9182443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control for recurrences of urinary bladder tumours by transabdominal ultrasonic scanning.
    Rosenkilde Olsen P; Jørgensen PM; Roed-Petersen K; Iversen HG; Iversen Hansen R; Wolf H
    Scand J Urol Nephrol; 1985; 19(2):105-7. PubMed ID: 3903978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transabdominal ultrasonography plus urine cytology in control of benign bladder tumours.
    Petersen SE; Lundbeck F; Brandsborg O; Steensskov V; Siem-Jørgensen P; Harving N; Wolf H
    Scand J Urol Nephrol Suppl; 1989; 125():121-5. PubMed ID: 2699073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Can the combination of bladder ultrasonography and urinary cytodiagnosis replace cystoscopy in the diagnosis and follow-up of tumors of the bladder?].
    Cariou G; Maaraoui N; Cortesse A
    Prog Urol; 1997 Feb; 7(1):51-5. PubMed ID: 9116739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasonography in the diagnosis of bladder tumours.
    Rózsahegyi J; Göblyös P; Bohár L; Szüle E
    Acta Chir Hung; 1985; 26(4):235-51. PubMed ID: 3909704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
    Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T;
    Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of ultrasonography in the diagnosis of bladder tumors].
    Rózsahegyi J; Magasi P; Göblyös P; Bohar L; Kiss F
    Rofo; 1985 Oct; 143(4):431-7. PubMed ID: 2997870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should follow-up cystoscopy in bacillus Calmette-Guérin-treated patients continue after five tumour-free years?
    Holmäng S; Ströck V
    Eur Urol; 2012 Mar; 61(3):503-7. PubMed ID: 22119022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative outcomes of primary, recurrent, and progressive high-risk non-muscle-invasive bladder cancer.
    Thomas F; Noon AP; Rubin N; Goepel JR; Catto JW
    Eur Urol; 2013 Jan; 63(1):145-54. PubMed ID: 22985746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alternatives to the cystoscopic control of bladder neoplasms].
    Páez Borda A; Luján Galán M; Martín Osés E; Berenguer Sánchez A
    Arch Esp Urol; 1997 Dec; 50(10):1079-83. PubMed ID: 9494196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Suprapubic bladder ultrasonography and urinary cytology: indications and limits in the follow-up of superficial bladder tumors].
    Pegoraro C; Bondavalli C; Molani L; Capitanio A; Schiavon L; Dall'Oglio B; Luciano M; Negri S
    Arch Ital Urol Nefrol Androl; 1991 Jun; 63 Suppl 2():127-9. PubMed ID: 1836650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transabdominal ultrasonography of the bladder as a staging examination for cervical carcinoma.
    de Jonge ET; Miskin S
    S Afr Med J; 1995 Oct; 85(10 Suppl):1076-80. PubMed ID: 8914555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting factors for recurrence in low-grade Ta primary bladder tumours.
    Molina Escudero R; Alvarez Ardura M; Ripalda Ferretti E; Crespo Martínez L; González Avila N; Dorado Valentín M; Páez Borda A
    Arch Esp Urol; 2014 Jul; 67(6):541-8. PubMed ID: 25048586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical course of superficial transitional carcinoma of the bladder without poor prognostic factors].
    Arrizabalaga Moreno M; Castro Pita M; Díez Rodríguez JM; García González JI; Navarro Sebastián J; Extramiana Cameno J; Esteban Artiaga R; Paniagaa Andrés P
    Actas Urol Esp; 1997 Mar; 21(3):187-94. PubMed ID: 9324883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study.
    Hermann GG; Mogensen K; Carlsson S; Marcussen N; Duun S
    BJU Int; 2011 Oct; 108(8 Pt 2):E297-303. PubMed ID: 21414125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
    Jancke G; Damm O; Rosell J; Jahnson S
    Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of very large superficial bladder tumours: a 10-year experience.
    Gupta SK; Parr NJ
    Scand J Urol Nephrol; 2008; 42(3):243-8. PubMed ID: 18432531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Echography and cystoscopy: 2 diagnostic means in bladder tumor (1)].
    Granados EA; de la Torre P; Palou J
    Actas Urol Esp; 1991; 15(6):540-2. PubMed ID: 1792992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transabdominal and transurethral scanning in the diagnosis of the bladder cancer stage].
    Stepanov VN; Perel'man VM; Abdukhakimov AF
    Urol Nefrol (Mosk); 1991; (2):33-7. PubMed ID: 2063502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound in the localisation of bladder tumours for radiotherapy treatment planning.
    Perkins AC; Price HM; Cox DJ; Thornhill P
    Br J Radiol; 1984 Mar; 57(675):241-5. PubMed ID: 6697085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.